Research articles
Magnetic hyperthermia in magnetic nanoemulsions: Effects of polydispersity, particle concentration and medium viscosity

https://doi.org/10.1016/j.jmmm.2017.05.076Get rights and content

Highlights

  • RF induced heating of magnetically polarizable nanoemulsions is studied.

  • The effects of size polydispersity and medium viscosity on heating efficiency are investigated.

  • Nanoemulsion with lower polydispersity exhibited a significantly higher SAR value.

  • Emulsion in agar showed low SAR value due to abrogation of Brownian relaxation.

Abstract

Magnetic fluid hyperthermia (MFH) is a promising cancer treatment modality where alternating magnetic field is used for heating cancerous cells loaded with magnetic nanofluids. Of late, it is realized that magnetic nano-carriers in the size range ∼100–200 nm (e.g. magnetic nanocomposites, magnetic liposomes and magnetic nanoemulsions) are ideal candidates for multimodal MFH coupled with drug delivery or photodynamic therapy due to enhanced permeation and retention (EPR) in the leaky vasculature of cancerous tissues. Here, we study the radiofrequency alternating magnetic field induced heating in magnetically polarizable oil-in-water nanoemulsions of hydrodynamic diameter ∼200 nm, containing single domain superparamagnetic nanoparticles of average diameter ∼10 nm in the oil phase. We probe the effects of size polydispersity of the droplets and medium viscosity on the field induced heating efficiency. The contribution of Neel and Brown relaxation of the magnetic nanoparticles on specific absorption rate (SAR) of the magnetic nanoemulsions, was found to increase linearly with the square of the applied field, with a maximum value of 164.4 ± 4.3 W/gFe. In magnetic nanoemulsions, the heating is induced by the Neel-Brown relaxation of the MNP over a length scale of 10 nm, and the whole scale Brownian relaxation of the emulsion droplets has over a length scale of 200 nm. The magnetic nanoemulsion sample with lower polydispersity (σ = 0.2) exhibited a significantly higher SAR value (3.3 times higher) as compared to the sample with larger polydispersity (σ = 0.4). The SAR values of the samples with 4.6 and 1.7 wt.% of MNP loading with σ values 0.4 a 0.3, respectively were comparable, suggesting a higher heating efficiency in nanofluid containing particles of lower size polydispersity even at lower particle loading. The emulsion droplets, immobilized in an agar matrix (4 wt.%), gave a maximum SAR value of 41.7 ± 2.4 W/gFe as compared to 111.8 ± 3.4 W/gFe in the case of droplets dispersed in water, which indicate a ∼40–50% drop in SAR due to abrogation of whole scale Brownian relaxation of the emulsion droplets. This suggests the need for improving the heating efficiency during actual therapy in tissues. The residual SAR of the immobilized sample correlates well with the SAR of the magnetic nanofluid, albeit under a lower external field amplitude due to demagnetization effect of the clusters of MNP loaded inside the droplets. The observed heating efficiency of larger sized magnetic nanoemulsion offer new possibilities for multimodal therapy due to availability of large volume for loading anti-cancer drug or photodynamic agents.

Introduction

Single domain superparamagnetic nanoparticles have been a topic of intense research during the last few decades due to their unique properties and diverse applications, especially in the biomedical field. Such single domain magnetic nanoparticles (MNP) in a host medium (viscous or viscoelastic) generate heat, under a high frequency alternating magnetic field, mainly due to the relaxation (Neel-Brownian) losses. The targeted and controlled field induced heating by MNPs have several applications in the field of biological sciences, e.g. enhanced drug release in the region of interest [1], [2], [3], magnetic fluid hyperthermia (MFH) [4], [5], [6], theranostic applications [7] and enhanced destruction of cancerous cells using combined therapies like photodynamic or chemotherapy paired with MFH [8], [9], [10]. MFH as a therapeutic procedure was first reported by Gilchrist et al. in 1957 [11], where a fluid containing MNP was injected into a tissue containing cancerous cells and thereafter exposed to a radio frequency (RF) alternating magnetic field which caused an increase in the fluid temperature beyond 42 °C (known as hyperthermia limit) that lead to cellular degradation and apoptosis [12]. Reports also suggest that cancerous cells exposed to the hyperthermia limit becomes more susceptible to conventional treatment methods like radiotherapy or chemotherapy [13], [14]. The high surface area to volume ratio of the MNP is found to be beneficial for promoting biological contact along with several other advantages like easy escape from vasculature, preferential conjugation with tumor cells for surface modified MNP and external magnetic field guided drug delivery. In vivo studies show good efficacy of MFH in curing various cancer modes like melanoma, breast tumors and prostate cancer [15], [16], [17]. Owing to its immense clinical benefits, MFH is being actively pursued as an alternative cancer treatment modality [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]. The field induced heating of magnetic nanoparticles is quantified in terms of a dosimetric quantity known as specific absorption rate (SAR) which is defined as the heat generated per unit mass (W/g). Experimentally, SAR is evaluated from the initial rate of temperature rise during the field induced heating in non-adiabatic limit where the increase in sample temperature is measured as a function of time using a suitable radio-frequency immune probe like fiber optic temperature sensor, liquid thermometer, infrared point thermometers and infrared thermography (IRT) [30], [31], [32].

Though numerous types of spinel ferrites, like cobalt, nickel, manganese, zinc, lanthanum, and strontium are used for MFH studies, the most widely used candidates for MFH applications are iron oxides (magnetite: Fe3O4 or maghemite: γ-Fe2O3); primarily due to their inherent biocompatibility (heme oxygenase-1 mediated metabolism) and ease of synthesis. These materials are used without or with inorganic/organic bio-compatible coatings. Recently, Kumar and Mohammed [33] broadened the definition of MFH to include magnetically modulated drug delivery, which opened up several interesting opportunities to use comparatively larger sized (∼ 200 nm diameter) nano-systems like, magnetic nano-composites [34], [35] and magnetic nanoemulsions. Such approaches are designed to make these system multifunctional, for e.g. specific anticancer drugs (like doxorubicin, paclitaxel or daunorubicin) attached to these materials for magnetically controlled drug delivery along with MFH [1] or use of photoactive chloroaluminum phthalocyanine (ClAlPc) agents with the MNP to combine photodynamic therapy and MFH [8], [36], [37]. Though superparamagnetic nanoparticles (SPM) are used in the most of the MFH studies, larger size nanoparticles are favorable for many applications, especially for multimodal applications [38], [39].

Studies show that nano-carriers loaded with anticancer drugs in the size range ∼100–200 nm, are beneficial for enhanced permeation and retention (EPR) in the local environment (consisting of leaky vasculature) of cancerous cells and to avoid uptake by macrophages, filtration at spleen or liver and human complement system which enhances the immunity against damaged cells and foreign inclusions [34], [40], [41]. Win and Feng [42] reported higher cellular uptake of the larger sized nanoparticles, which was found to be beneficial to increase the drug delivery ratio to the affected cells. A higher SAR for ∼200 nm sized ultra-magnetic liposomes particles has been reported by Bealle et al. [43]. It has been reported that for doxorubicin loaded (loading efficiency ∼80%) polyethylene glycol coated and carboxyl enriched mesoporous MgFe2O4 samples, MFH in combination with drug therapy results in ∼90% cell deaths in vitro as compared to MFH only [44]. Paula et al. reported a 70% increase in cell death during simultaneous application of photodynamic therapy and MFH [8]. The above studies show that comparatively larger sized nano-carriers are essential for achieving synergistic multimodal therapy. Recent studies indicate that high macroscopic temperature rise is not a prerequisite for MFH induced drug delivery thereby opening up the possibilities of using nano-carriers with even lower concentration of magnetic phases as multi-modal MFH agents [45].

Magnetic nanoemulsions is an ideal model candidate for larger sized nano-carriers due to its structural and dimensional similarities with encapsulated ultra-magnetic liposomes (UML) [34], [43]. Magnetically polarizable nanoemulsions have been used as smart sensors for non-enzymatic glucose detection [46], nano-scale mechanical probes and actuators in complex fluids and biological systems [47] and magnetic resonance imaging [48]. Iron oxide modified oil-in-water magnetic nanoemulsion, with the magnetic particles distributed in the water phase and the oil phase containing photodynamic agents like chloroaluminum phthalocyanine or Zn(II)-phthalocyanine were used for simultaneous photodynamic therapy and MFH [8], [36], [37]. Hu et al. [49] reported the use of bio-compatible core-shell, water-in-oil-in-water double emulsion, where poly vinyl alcohol and magnetic iron oxide nanoparticles were used as surfactant and stabilizing agent, respectively as a dual-drug carrier with controlled drug release.

Although field induced heating of magnetic nanoemulsions have been demonstrated previously, to the best of our knowledge, systematic studies on the field induced heating efficiency of magnetic nanoemulsions were not carried out earlier, in spite of having tremendous potential for multimodal MFH agents. Though the field induced heating in MNP based nanofluid is well studied, several challenges still exist in the basic understanding of the heating mechanism in magnetic nanoemulsions and magnetic clusters. Despite the fact that the role of polydispersity [23], [50], demagnetizing field [51], [52] and dipole-dipole interactions [20], [53] on heating efficiency is studied theoretically (analytically or numerically), the experimental work, which is essential for practical applications, on these aspects in model colloidal system consisting of magnetic nanoemulsion is scarce. In magnetic nanoemulsion, both the MNP’s (10 nm) and the droplets (20 times bigger at ∼200 nm) acts as heat generators. Due to larger size of the emulsion droplets, Brownian relaxation is the dominant heating mechanism, whereas in the case of MNP, both Neel and Brownian contributions are present. The size and polydispersity of the droplets play a crucial role in heat generation through Brownian relaxation. The effect of demagnetizing field and inter-particle interaction also needs to be understood well for effective utilization of MFH towards cancer treatment. Finally, the role of interfacial thermal resistance and dispersion medium viscosity on the heat transfer from the droplets to the dispersion medium needs to be understood clearly.

The main aim of this work was to systematically study the field induced heating of an oil-in-water magnetic nanoemulsions of size ∼200 nm containing MNPs (∼10 nm). The second objective was to probe the role of polydispersity of the oil droplets (with same size and concentrations of the loaded MNP) on the heating efficiency of the nanoemulsions. The third objective was to compare the heating efficiency with and without Brownian relaxation mechanism (studied by immobilizing of the emulsion droplets in tissue mimicking agar gel) and to study the effect of demagnetizing field on heating efficiency. We also probe the morphological consistency of the emulsion droplets immobilized in agar gel. The experimentally obtained data were also compared with theoretical results obtained under linear response regime.

Section snippets

Mechanism of field induced heating in magnetic nanoparticle (MNP) dispersions

Alternating magnetic field can induce heating in MNP via three major heating mechanisms, viz. hysteresis loss (for large single domain or multi domain MNP) and Neel-Brown relaxation mechanisms (for SPM MNP) [12], [23]. In the case of hysteresis loss, power dissipated (P) can be expressed as P = A.f, where A and f indicate hysteresis loop area (in general, minor loops for MFH applications) and frequency of the applied magnetic field, respectively. On the other hand, for SPM MNP, P can be expressed

Materials

Fe3O4 MNP were synthesized by a chemical co-precipitation technique using 1:1 acidic solution of 0.8 M FeCl3·6H2O and 0.4 M FeSO4·7H2O [69]. The Fe3O4 MNP were coated with oleic acid to provide stabilization against van der Waals attraction and the coated MNP were dispersed in octane (indicated as O1 hereafter). Using a classical inversion method, oil-in-water stock emulsion (size  0.1–1 μm) was prepared, from which monodisperse emulsion with narrow size distribution was obtained using

Properties of the MNP and magnetic nanoemulsion

Fig. 1a shows the powder XRD pattern of the uncoated magnetic nanoparticles at room temperature where the Bragg reflection peaks corresponding to (2 2 0), (3 1 1), (4 0 0), (4 2 2), (5 1 1) and (4 4 0) planes of cubic spinel structure of Fe3O4 (JCPDS file No. 19-0629) are clearly discernible. It should be noted that magnetite (Fe3O4) and maghemite (γ-Fe2O3) have identical XRD diffraction patterns and hence, Mossbauer spectroscopic studies are used for the exact phase identifications [74]. Magnetite has an

Conclusions

The radiofrequency alternating magnetic field induced heating in magnetically polarizable oil-in-water nanoemulsions containing single domain superparamagnetic nanoparticles was experimentally studied. The effects of size polydispersity, MNP concentration and medium viscosity were probed in detail. The specific absorption rate (SAR) of the MNP based nanofluid was studied under five different external field amplitudes where it was observed that the SAR increased linearly with the square of the

Conflict of interest

The authors declare no conflict of interest.

Acknowledgement

The authors wish to thank Dr. Saroja Saibaba, Dr. G. Amarendra and Dr. A. K. Bhaduri for their support and encouragement.

References (94)

  • B.B. Lahiri et al.

    Magnetic hyperthermia study in water based magnetic fluids containing TMAOH coated Fe3O4 using infrared thermography

    Infrared Phys. Technol.

    (2017)
  • C.S.S.R. Kumar et al.

    Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery

    Adv. Drug Deliv. Rev.

    (2011)
  • M.M. Goswami et al.

    Micelles driven magnetite (Fe3O4) hollow spheres and a study on AC magnetic properties for hyperthermia application

    J. Magn. Magn. Mater.

    (2016)
  • U. Gaur et al.

    Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system

    Int. J. Pharm.

    (2000)
  • G.T. Landi et al.

    AC susceptibility as a tool to probe the dipolar interaction in magnetic nanoparticles

    J. Magn. Magn. Mater.

    (2017)
  • X. Wang et al.

    The heating effect of magnetic fluids in an alternating magnetic field

    J. Magn. Magn. Mater.

    (2005)
  • S. Kalele et al.

    Probing temperature-sensitive behavior of pNIPAAM-caoted iron oxide nanoparticles using frequency-dependent magnetic measurements

    J. Magn. Magn. Mater.

    (2009)
  • T. Morita et al.

    Multiple small-angle X-ray scattering analyses of the structure of gold nanorods with unique end caps

    Chem. Phys.

    (2009)
  • K. Yang et al.

    Re-examination of characteristic FTIR spectrum of secondary layer in bilayer oleic acid-coated Fe3O4 nanoparticles

    Appl. Surf. Sci.

    (2010)
  • M. Gonzales-Weimuller et al.

    Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia

    J. Magn. Magn. Mater.

    (2009)
  • V.N. Nikiforov et al.

    Magnetism and Verwey transition in magnetite nanoparticles in thin polymer film

    J. Alloys Compd.

    (2013)
  • S. Chen et al.

    Simulating physiological conditions to evaluate nanoparticles for magnetic fluid hyperthermia (MFH) therapy applications

    J. Magn. Magn. Mater.

    (2010)
  • S. Brule et al.

    Doxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapy

    Adv. Mater.

    (2011)
  • P.I.P. Soares et al.

    Thermal and magnetic properties of iron oxide colloids: influence of surfactants

    Nanotechnology

    (2015)
  • D. Yoo et al.

    Theranostic magnetic nanoparticles

    Acc. Chem. Res.

    (2011)
  • L.B.D. Paula et al.

    Combination of hyperthermia and photodynamic therapy on mesenchymal stem cell line treated with chloroaluminum phthalocyanine magnetic-nanoemulsion

    J. Magn. Magn. Mater.

    (2015)
  • B. Sahoo et al.

    Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anti-cancer drug

    ACS Appl. Mater. Interfaces

    (2013)
  • S. Rana et al.

    Stimuli responsive carboxyl PEGylated Fe3O4 nanoparticles for Therapeutic applications

    J. Nanofluids

    (2015)
  • R.K. Gilchrist et al.

    Selective inductive heating of lymph nodes

    Ann. Surg.

    (1957)
  • Q.A. Pankhurst et al.

    Application of magnetic nanoparticles in biomedicine

    J. Phys. D Appl. Phys.

    (2003)
  • Q.A. Pankhurst et al.

    Progress in applications of magnetic nanoparticles in biomedicine

    J. Phys. D Appl. Phys.

    (2009)
  • A. Ito et al.

    Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma

    Cancer Sci.

    (2003)
  • I. Hilger et al.

    Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study

    Invest. Radiol.

    (2002)
  • M. Johannsen et al.

    Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique

    Int. J. Hyperth.

    (2005)
  • J.-H. Lee et al.

    Exchange-coupled magnetic nanoparticles for efficient heat induction

    Nat. Nanotechnol.

    (2011)
  • S. Ruta et al.

    Unified model of hyperthermia via hysteresis heating in systems of interacting magnetic nanoparticles

    Sci. Rep.

    (2015)
  • C. Haase et al.

    Role of dipole-dipole interactions for hyperthermia heating of magnetic nanoparticle ensembles

    Phys. Rev. B

    (2012)
  • I. Conde-Leboran et al.

    A single picture explains diversity of hyperthermia response of magnetic nanoparticles

    J. Phys. Chem. C

    (2015)
  • A. Urtizberea et al.

    Specific absorption rate and magnetic properties of ferrofluids with interaction effects at low concentration

    J. Phys. Chem. C

    (2010)
  • P. Guardia et al.

    Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment

    ACS Nano

    (2012)
  • P.-E.L. Renard et al.

    Magnetic and in vitro heating properties of implants formed in situ from injectable formulations and containing superparamagnetic iron oxide nanoparticles (SPIONs) embedded in silica microparticles for magnetically induced local hyperthermia

    J. Magn. Magn. Mater.

    (2011)
  • M. Knobel et al.

    Superparamagnetism and other magnetic features in granular materials: a review on ideal and real systems

    J. Nanosci. Nanotechnol.

    (2008)
  • R.O. Rodrigues, H.T. Gomes, R. Lima, A.M.T. Silva, P.J.S. Rodrigues, P.B. Tavares, J.M.R.S. Tavares, Thermal infrared...
  • X.L. Liu et al.

    Magnetic naoparticle-loaded polymer nanospheres as magnetic hyperthermia agents

    J. Mat. Chem. B

    (2014)
  • L.B.D. Paula et al.

    Development, characterization, and in vitro trials of chloroaluminum phthalocyanine-magnetic nanoemulsion to hyperthermia and photodynamic therapies on glioblastoma as a biological model

    J. Appl. Phys.

    (2012)
  • F.L. Primo et al.

    Photosensitizer-loaded magnetic nanoemulsion for use in synergic photodynamic and magnetohyperthermia therapies of neoplastic cells

    J. Nanosci. Nanotech.

    (2008)
  • S.M. Moghimi et al.

    Long-circulating and target-specific nanoparticles: theory to practice

    Pharmacol. Rev.

    (2001)
  • Cited by (0)

    View full text